Previous clinical studies investigated the association between serum IGF‐1 levels and tumor aggressiveness, but their results were not consistent with the epidemiologic data28, 29, 30 due to small sample size, such that they had insufficient statistical power to discriminate tumor grade. Here, IGF1 is linked to neoplasm.